Konstantin S. Spirin
About
In The Last Decade
Konstantin S. Spirin
15 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 86
- Molecular Biology 651
- Oncology 449
- Cancer Research 137
- Radiology, Nuclear Medicine and Imaging 133
- Cell Biology 102
Countries citing papers authored by Konstantin S. Spirin
This map shows the geographic impact of Konstantin S. Spirin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konstantin S. Spirin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konstantin S. Spirin more than expected).
Fields of papers citing papers by Konstantin S. Spirin
This network shows the impact of papers produced by Konstantin S. Spirin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konstantin S. Spirin. The network helps show where Konstantin S. Spirin may publish in the future.
Co-authorship network of co-authors of Konstantin S. Spirin
This figure shows the co-authorship network connecting the top 25 collaborators of Konstantin S. Spirin. A scholar is included among the top collaborators of Konstantin S. Spirin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Konstantin S. Spirin. Konstantin S. Spirin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 229 | |
| 2 | 96 | |
| 3 | 73 | |
| 4 | 26 | |
| 5 | Expression of tenascin-C splice variants in normal and bullous keratopathy human corneas. | 41 |
| 6 | 19 | |
| 7 | 4 | |
| 8 | 6 | |
| 9 | Alterations of the cyclin-dependent kinase inhibitor p19 (INK4D) is rare in hematopoietic malignancies. | 21 |
| 10 | p27/Kip1 mutation found in breast cancer. | 146 |
| 11 | 23 | |
| 12 | 63 | |
| 13 | Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. | 275 |
| 14 | 29 | |
| 15 | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.